Related content

Treatment with granulocyte–macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock

By Schefold Joerg C.   Zeden Jan-Philip   Pschowski Rene   Hammoud Ben   Fotopoulou Christina   Hasper Dietrich   Fusch Gerhard   Haehling Stephan Von   Volk Hans-Dieter   Meisel Christian   Schütt Christine   Reinke Petra  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 3, 2010-02 ,pp. : 164-171

Informa Healthcare

Access to resources Recommend Favorite

Effects of granulocyte-macrophage colony-stimulating factor and cyclic AMP interaction on human neutrophil apoptosis

By Tortorella Cosimo   Piazzolla Giuseppina   Spaccavento Felice   Antonaci Salvatore  

Mediators of Inflammation, Vol. 7, Iss. 6, 1998-12 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

Successful Treatment of Chronic Disseminated Candidiasis with Fluconazole and a Granulocyte–Macrophage Colony-stimulating Factor Combination

By Rókusz László   Liptay László   Kádár Katalin  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 10, 2001-10 ,pp. : 784-786

Informa Healthcare

Access to resources Recommend Favorite

Granulocyte-Macrophage Colony-Stimulating Factor and Interferon-Alpha 2B in Patients with Advanced Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 61, Iss. 4, 1999-06 ,pp. : 215-219

Karger

Access to resources Recommend Favorite

Subcutaneous Granulocyte-Macrophage Colony-Stimulating Factor in Mucositis Induced by an Adjuvant 5-Fluorouracil plus Leucovorin Regimen

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 353-360

Karger

Access to resources Recommend Favorite